$Novavax(NVAX)$ It's unfortuna

Like
Comment
Favorite

$Novavax(NVAX)$ It's unfortunate -- so retail baggies got sucked into this -- now it's thrashed ... and in the AH it continues. Terrible signal for the balance of this week and month of May. NVAX is going lower, much lower.

NVAX will be down in the $4-$6 range by the end of the month. Even with the Sanofi deal, this company's revenue is set to decrease over the next year. No way this bump lasts.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":306536512057424,"tweetId":"306536512057424","gmtCreate":1715856283475,"gmtModify":1715856287821,"author":{"id":9000000000000488,"authorId":9000000000000488,"authorIdStr":"9000000000000488","name":"MatthewWalter","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body> <a data-mention-id=\"NVAX\" class=\"teditor-mention\" data-mention-name=\"Novavax\" href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a> <v-v data-views=\"0\"></v-v>It's unfortunate -- so retail baggies got sucked into this -- now it's thrashed ... and in the AH it continues. Terrible signal for the balance of this week and month of May. NVAX is going lower, much lower.NVAX will be down in the $4-$6 range by the end of the month. Even with the Sanofi deal, this company's revenue is set to decrease over the next year. No way this bump lasts.</body></html>","htmlText":"<html><head></head><body> <a data-mention-id=\"NVAX\" class=\"teditor-mention\" data-mention-name=\"Novavax\" href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a> <v-v data-views=\"0\"></v-v>It's unfortunate -- so retail baggies got sucked into this -- now it's thrashed ... and in the AH it continues. Terrible signal for the balance of this week and month of May. NVAX is going lower, much lower.NVAX will be down in the $4-$6 range by the end of the month. Even with the Sanofi deal, this company's revenue is set to decrease over the next year. No way this bump lasts.</body></html>","text":"$Novavax(NVAX)$ It's unfortunate -- so retail baggies got sucked into this -- now it's thrashed ... and in the AH it continues. Terrible signal for the balance of this week and month of May. NVAX is going lower, much lower. NVAX will be down in the $4-$6 range by the end of the month. Even with the Sanofi deal, this company's revenue is set to decrease over the next year. No way this bump lasts.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/306536512057424","repostId":0,"isVote":1,"tweetType":1,"viewCount":652,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVAX"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":324,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}